Contract Biologics Manufacturing, Biosimilars
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT06193408
Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 11, 2024
Completion: Sep 8, 2024
Loading map...